+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Bioreactors Market Forecast to 2027 - COVID-19 Impact - Regional Analysis and Market Forecasts by Cell, Molecule, Technology and End User

  • ID: 5116937
  • Report
  • June 2020
  • Region: Europe
  • 160 Pages
  • The Insight Partners
UP TO OFF until Jun 30th 2022

FEATURED COMPANIES

  • Applikon Biotechnology BV
  • bbi-biotech GmbH
  • Cellexus
  • GEA Group
  • MERCK KGaA
  • Sartorius AG
The European bioreactors market is expected to reach US$ 1,512.45 Mn by 2027 from US$ 885.26 Mn in 2019. The market is estimated to grow at a CAGR of 7.0% from 2020 to 2027.The growth of The European bioreactors market is primarily attributed to the rapidly growing biopharmaceutical and biotechnology industries and increasing adoption of single-use bioreactors. However, stringent regulatory frameworks in different countries hinder the market growth in the region. Additionally, technological advancements in bioreactors and rising demand for personalized medicines are likely to boost the growth of The European bioreactors market during the forecast period.

A bioreactor is equipment or system engineered to provide biologically active environment for the production of various medical and pharmaceutical compounds. The vessel is used to carry out a chemical process, which involves organisms or biochemically active substances derived from such organisms. This process can either be aerobic or anaerobic. Bioreactors are commonly cylindrical in shape, ranging in capacities from liters to cubic meters, and are generally made of stainless steel. Bioreactors provide a controllable environment, in terms of pH, temperature, nutrient supply, and shear stress. These equipment are used in a variety of applications, such as production of biopharmaceuticals and tissue engineering products.

The pharmaceuticals industry has been growing at an unprecedented pace in the recent years, and with this the biopharmaceuticals market is also expanding. With the aging population and rising healthcare standards, the demand for pharmaceutical products has been escalating in European countries. The strong demand for drugs and pharmaceuticals has been driving the growth of The European bioreactors market. Moreover, increasing approvals in gene and cell therapies are favoring the growth of the bioreactors market in Europe. The approved gene therapies are Glybera-used to treat Lipoprotein Lipase Deficiency, and Strimvelis- treating ADA-Severe Combined Immunodeficiency. The factors mentioned above are increasing the demand for the large-scale production of various therapeutic substances, thereby encouraging companies to deploy more bioreactors in their production facilities.

Europe has been massively hit by the recent COVID-19 pandemic that has affected many of its countries on a large scale. Italy, Germany, Spain, the UK, and France, among others, are continually witnessing rise in number of positive cases every day. The dependency of European country on China for raw materials is hampering the pharmaceutical supply in the region. These factors are majorly anticipated to hamper the growth of the market in Europe. According to data published in a newsletter in March 2020, Majority of the European pharmaceutical companies have manufacturing facilities located in India, while they procure ~70.0% of the raw ingredients from China. Thus, the lockdown and industrial shutdown in different countries are likely to hamper whole supply chain, which will ultimately hamper the growth of the bioreactors market inEurope.

In 2019, the mammalian cells segment accounted for the largest share of the Europe bioreactors market. However, the yeast cells segment is estimated to report the highest CAGR during the forecast period. Yeasts are cost-effective, fast-growing, and can be used for high-density cell cultures in bioreactors. Moreover rapid growth rate, easy genetic manipulation, complete genome sequence knowledge, cost-effective growth medium requirements, and post-translational modifications flexibility make yeasts perfect hosts for recombinant protein expression.

A few of the significant secondary sources referred to while preparing the report on the Europe bioreactors market report include the World Health Organization (WHO) andEuropean Medicines Agency (EMA).

Reasons to Buy:
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in The European Bioreactors Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in The European Bioreactors market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Applikon Biotechnology BV
  • bbi-biotech GmbH
  • Cellexus
  • GEA Group
  • MERCK KGaA
  • Sartorius AG

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Bioreactors Market - By Cell
1.3.2 Europe Bioreactors Market - By Molecule
1.3.3 Europe Bioreactors Market - By Technology
1.3.4 Europe Bioreactors Market- By End User
1.3.5 Europe Bioreactors Market - By Country
2. Europe Bioreactors Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Bioreactors Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Bioreactors Market - Europe PEST Analysis
4.3 Expert Opinion
5. Europe Bioreactors Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Adoption of Single-Use Bioreactors
5.1.2 Rapid Growth of Biopharmaceutical and Biotechnology Companies
5.2 Key Market Restraints
5.2.1 Stringent Regulatory Framework
5.3 Key Market Opportunities
5.3.1 Rising Demand of Personalized Medicine
5.4 Future Trends
5.4.1 Robust Technological Advancements in Bioreactors
5.5 Impact Analysis
6. Bioreactors Market - Europe Analysis
6.1 Europe Bioreactors Market Revenue Forecasts and Analysis
7. Europe Bioreactors Market Analysis And Forecasts To 2027 - By Cell
7.1 Overview
7.2 Europe Bioreactors market, By Cell 2019 & 2027 (%)
7.2.1 Europe Bioreactors Market Revenue and Forecasts to 2027, By Cell (US$ Mn)
7.3 Mammalian Cells
7.3.1 Overview
7.3.2 Europe Mammalian Cells Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Bacterial Cells
7.4.1 Overview
7.4.2 Europe Bacterial Cells Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Yeast Cells
7.5.1 Overview
7.5.2 Europe Yeast Cells Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Others
7.6.1 Overview
7.6.1.1 Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)
8. Europe Bioreactors Market Analysis - By Molecule
8.1 Overview
8.2 Europe Bioreactors Market, By Molecule 2019-2027 (%)
8.2.1 Europe Bioreactors Market Revenue and Forecasts to 2027, By Molecule (US$ Mn)
8.3 Monoclonal Antibodies
8.3.1 Overview
8.3.2 Europe Monoclonal Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Vaccines
8.4.1 Overview
8.4.2 Europe Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Recombinant Proteins
8.5.1 Overview
8.5.2 Europe Recombinant Proteins Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Stem Cells
8.6.1 Overview
8.6.2 Europe Stem Cells Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Gene Therapy
8.7.1 Overview
8.7.2 Europe Gene Therapy Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Others
8.8.1 Overview
8.8.2 Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. Europe Bioreactors Market Analysis - By Technology
9.1 Overview
9.2 Europe Bioreactors Market, By Technology 2019-2027 (%)
9.2.1 Europe Bioreactors Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
9.3 Wave-Induced Motion SUB
9.3.1 Overview
9.3.2 Europe Wave-Induced Motion SUB Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Stirred SUB
9.4.1 Overview
9.4.2 Europe Stirred SUB Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Single-Use Bubble Column
9.5.1 Overview
9.5.2 Europe Single-Use Bubble Column Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Other Technologies
9.6.1 Overview
9.6.2 Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)
10. Europe Bioreactors Market Analysis - By End-User
10.1 Overview
10.2 Europe Bioreactors Market, By End-User 2019-2027 (%)
10.2.1 Europe Bioreactors Market Revenue and Forecasts to 2027, By End-User (US$ Mn)
10.3 Research and Development Organizations
10.3.1 Overview
10.3.2 Europe Research and Development Organizations Market Revenue and Forecasts to 2027 (US$ Mn)
10.4 Biopharma Manufacturers
10.4.1 Overview
10.4.2 Europe Biopharma Manufacturers Market Revenue and Forecasts to 2027 (US$ Mn)
10.5 Contract Manufacturing Organisations (CMOs)
10.5.1 Overview
10.5.2 Europe Contract Manufacturing Organisations Market Revenue and Forecasts to 2027 (US$ Mn)
11. Bioreactors Market Revenue and Forecasts To 2027 - Geographical Analysis
11.1 Europe Bioreactors Market Revenue and Forecasts To 20
11.1.1 Overview
11.1.2 Europe Bioreactors Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.3 Europe Bioreactors Market, by Cell - Revenue and Forecast to 2027 (USD Million)
11.1.4 Europe Bioreactors Market, by Molecule - Revenue and Forecast to 2027 (USD Million)
11.1.5 Europe Bioreactors Market, by Technology - Revenue and Forecast to 2027 (USD Million)
11.1.6 Europe Bioreactors Market, by End User - Revenue and Forecast to 2027 (USD Million)
11.1.7 Europe: Bioreactors Market, by Country, 2019 & 2027 (%)
11.1.7.1 Germany: Bioreactors Market- Revenue and Forecasts to 2027 (USD Million)
11.1.7.1.1 Germany: Bioreactors Market- Revenue and Forecasts to 2027 (USD Million)
11.1.7.1.2 Germany Bioreactors Market, by Cell - Revenue and Forecast to 2027 (USD Million)
11.1.7.1.3 Germany Bioreactors Market, by Molecule - Revenue and Forecast to 2027 (USD Million)
11.1.7.1.4 Germany Bioreactors Market, by Technology - Revenue and Forecast to 2027 (USD Million)
11.1.7.1.5 Germany Bioreactors Market, by End User - Revenue and Forecast to 2027 (USD Million)
11.1.7.2 UK: Bioreactors Market - Revenue and Forecast to 2027 (USD Million)
11.1.7.2.1 UK: Bioreactors Market - Revenue and Forecast to 2027 (USD Million)
11.1.7.2.2 UK Bioreactors Market, by Cell - Revenue and Forecast to 2027 (USD Million)
11.1.7.2.3 UK Bioreactors Market, by Molecule - Revenue and Forecast to 2027 (USD Million)
11.1.7.2.4 UK Bioreactors Market, by Technology - Revenue and Forecast to 2027 (USD Million)
11.1.7.2.5 UK Bioreactors Market, by End User - Revenue and Forecast to 2027 (USD Million)
11.1.7.3 France: Bioreactors Market- Revenue and Forecasts to 2027 (USD Million)
11.1.7.3.1 France: Bioreactors Market- Revenue and Forecasts to 2027 (USD Million)
11.1.7.3.2 France Bioreactors Market, by Cell - Revenue and Forecast to 2027 (USD Million)
11.1.7.3.3 France Bioreactors Market, by Molecule - Revenue and Forecast to 2027 (USD Million)
11.1.7.3.4 France Bioreactors Market, by Technology - Revenue and Forecast to 2027 (USD Million)
11.1.7.3.5 France Bioreactors Market, by End User - Revenue and Forecast to 2027 (USD Million)
11.1.7.4 Italy Bioreactors Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.7.4.1 Italy: Bioreactors Market- Revenue and Forecasts to 2027 (USD Million)
11.1.7.4.2 Italy Bioreactors Market, by Cell - Revenue and Forecast to 2027 (USD Million)
11.1.7.4.3 Italy Bioreactors Market, by Molecule - Revenue and Forecast to 2027 (USD Million)
11.1.7.4.4 Italy Bioreactors Market, by Technology - Revenue and Forecast to 2027 (USD Million)
11.1.7.4.5 Italy Bioreactors Market, by End User - Revenue and Forecast to 2027 (USD Million)
11.1.7.5 Spain Bioreactors Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.7.5.1 Spain: Bioreactors Market- Revenue and Forecasts to 2027 (USD Million)
11.1.7.5.2 Spain Bioreactors Market, by Cell - Revenue and Forecast to 2027 (USD Million)
11.1.7.5.3 Spain Bioreactors Market, by Molecule - Revenue and Forecast to 2027 (USD Million)
11.1.7.5.4 Spain Bioreactors Market, by Technology - Revenue and Forecast to 2027 (USD Million)
11.1.7.5.5 Spain Bioreactors Market, by End User - Revenue and Forecast to 2027 (USD Million)
12. Impact Of COVID-19 Pandemic on Europe Bioreactors Market
12.1 Europe: Impact Assessment of COVID-19 Pandemic
13. COMPANY PROFILES
13.1 Sartorius AG
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Cellexus
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 bbi-biotech GmbH
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 GEA Group
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Applikon Biotechnology BV
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 MERCK KGaA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Sartorius AG
  • Cellexus
  • bbi-biotech GmbH
  • GEA Group
  • Applikon Biotechnology BV
  • MERCK KGaA
Note: Product cover images may vary from those shown